Review Article

Role of Mesotherapy in Musculoskeletal Pain: Opinions from the Italian Society of Mesotherapy

Table 3

Clinical studies conducted in athletes both professional and amatory with posttraumatic pain.

StudyDiseaseNo. of patientsStudy characteristicsDrugs utilizedControlPeriod of followupNo. of sessionsOutcome

Cereser et al. 1985 [47]Pain posttraumatic in rugby professional players133R ONSAIDs, myorelaxant, vasorelaxant, and mepivacaineNCup to 4 months1–4 sessionsPain reduction and functional recovering of sporting competitive activity in shorter time then conventional therapies

Gribaudo et al. 1982 [48]Pubic myoenthesitis256P ONSAIDs and vasorelaxantNC6 monthsfrom 2 to 5 sessions at 10–20-day intervalsComplete functional recovery after 4 sessions

Lepore and Savino 1983 [49]Acute lumbosciatic pain in athletes20P ONeuramidium, ProcaineNC4 months2–6 sessionsPain reduction and functional recovery in 90% of pts

Gribaudo et al. 1986 [50]Patellar tendonitis126P OSuperoxide dismutase (SOD), lidocaine, and vasorelaxantNC1 monthweekley sessions85% of pts reach complete pain relief (form 1 to 4 sessions)

Gribaudo et al. 1986 [51]Ileo-tibial band friction syndrome40P ONSAIDS, vasorelaxant, and anestheticNC3 monthsweekly sessionsPain relief in 55% of pts after 2 sessions; 97.5% after 3 sessions

Gribaudo et al. 1987 [52]Myonthesitis of the leg203P ONSAIDs, vasorelaxant, and lidocaineNC2 monthssessions at 7-8-day intervals60.8% of pts reach complete recovery with 1 session; 96.6% of pts reach complete recovery with 3 sessions. Mesotherapy was more efficacy in pts with recent pain.

The table lists clinical studies to evaluate the reduction of pain in various clinical conditions. The pain was noted with visual scales.
R: retrospective, P: Prospective, O: open, and NC: noncontrolled.